Advanced glycation end products and their receptors did not show any association with body mass parameters in metabolically healthy adolescents

Acta Paediatr. 2018 Dec;107(12):2146-2151. doi: 10.1111/apa.14426. Epub 2018 Jun 19.

Abstract

Aim: We determined the relationship between circulating advanced glycation end products (AGEs), AGE receptors and homeostatic model assessment for insulin resistance (HOMA-IR) in metabolically healthy obese and normal weight adolescents.

Methods: In 2015, we recruited 80 normal weight adolescents and 80 with obesity from schools Leon city, Mexico, and put them into metabolically healthy (HOMA-IR <3.0) and unhealthy (HOMA-IR >3.0) groups. We measured their body mass index (BMI) and carried out detailed blood analyses.

Results: We found a higher triglycerides, triglycerides/high-density lipoproteins cholesterol (TG/HDL-C) index, HOMA-IR, tumour necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) in the metabolically healthy group and found correlations between HOMA-IR with BMI, the TG/HDL-C index and IL-6 and the TG/HDL-C index and BMI and (TNF-α). There was no correlation between markers of obesity and circulating N-carboxymethyl-lysine (CML) or soluble receptor for advanced glycation end products (sRAGE). Some unhealthy adolescents had higher CML (15.5 ± 2.7 U/mL, p < 0.028) and sRAGE (3123 ± 1364 pg/mL, p < 0.001) than the healthy group.

Conclusion: HOMA-IR and the TG/HDL-C index were associated with BMI and inflammation markers. CML and sRAGE were not associated with obesity or inflammation. These parameters were higher in unhealthy obese adolescents.

Keywords: Adolescents; Advanced glycation end products; Insulin resistance; Metabolically healthy obese; Soluble receptor for advanced glycation end products.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Body Mass Index
  • Case-Control Studies
  • Cross-Sectional Studies
  • Female
  • Glycation End Products, Advanced / blood*
  • Humans
  • Male
  • Obesity / blood*
  • Receptor for Advanced Glycation End Products / blood*

Substances

  • AGER protein, human
  • Glycation End Products, Advanced
  • Receptor for Advanced Glycation End Products